menorrhagia. Excessive and frequent menstruation with regular cycle
Conditions
Interventions
Intervention 1: The intervention group:the women will be received 1 gram of sumac capsules and Tranxamic acid capsule contain 500 mg, 3 times in a day, from the first day until the seventh menstrual
Treatment - Drugs
The intervention group:the women will be received 1 gram of sumac capsules and Tranxamic acid capsule contain 500 mg, 3 times in a day, from the first day until the seventh menstrual cycle for 3 cyc
Control group: the women in control group will be received Tranxamic acid capsule contain 500 mg, 3 times in a day, from the first day until the seventh cycle period for 3 cycles
Sponsors
vice chancellor for research,shiraz university of medical science
Eligibility
Sex/Gender
Female
Age
20 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: 1) willingness to cooperate 2) having 20-45 years of age, 3) getting to the doctor menorrhagia 4) lack of hemoglobin less than 10 5) no history of gastrointestinal and liver diseases, renal and cerebral thrombosis and history coagulopathies 6) lack of sensitivity to the metal and acid Tranksmyk 7) view of Bdny29-19 8) absence of polyps and fibroids 9) lack of uterine malignancies 10) using non-hormonal contraceptive IUD Wow 11) score of 100 the PBAC exclusion criteria: 1) lack of desire to continue participating in the study, 2) reduction of hemoglobin below 10 3) complications associated with treatment for the patient
Exclusion criteria
Exclusion criteria:
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Anemia. Timepoint: Before the intervention, one month after the end of the cycle, the second month after the third month after menstruation and menstrual cycle. Method of measurement: PT.PTT.CBC,Fibrinogen Level?Serum Iron. | — |
Primary
| Measure | Time frame |
|---|---|
| Amount OF uterine bleeding. Timepoint: Before the intervention, one month after the intervention (at the end of the first menstrual cycle), second month, third month after menstruation and after menstruation cycle. Method of measurement: Pictorial Blood Loss Assessment Chart. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMasoumeh Kaviani
School of Nursing and Midwifery,Shiraz University of Medical Sciences,
Outcome results
None listed